1. Home
  2. BOLD vs POCI Comparison

BOLD vs POCI Comparison

Compare BOLD & POCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • POCI
  • Stock Information
  • Founded
  • BOLD 2018
  • POCI 1982
  • Country
  • BOLD United States
  • POCI United States
  • Employees
  • BOLD N/A
  • POCI N/A
  • Industry
  • BOLD
  • POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • BOLD
  • POCI Health Care
  • Exchange
  • BOLD Nasdaq
  • POCI Nasdaq
  • Market Cap
  • BOLD 30.3M
  • POCI 32.4M
  • IPO Year
  • BOLD 2024
  • POCI N/A
  • Fundamental
  • Price
  • BOLD $1.44
  • POCI $4.63
  • Analyst Decision
  • BOLD Hold
  • POCI
  • Analyst Count
  • BOLD 1
  • POCI 0
  • Target Price
  • BOLD N/A
  • POCI N/A
  • AVG Volume (30 Days)
  • BOLD 61.2K
  • POCI 27.6K
  • Earning Date
  • BOLD 05-09-2025
  • POCI 05-14-2025
  • Dividend Yield
  • BOLD N/A
  • POCI N/A
  • EPS Growth
  • BOLD N/A
  • POCI N/A
  • EPS
  • BOLD N/A
  • POCI N/A
  • Revenue
  • BOLD N/A
  • POCI $18,682,766.00
  • Revenue This Year
  • BOLD N/A
  • POCI N/A
  • Revenue Next Year
  • BOLD N/A
  • POCI N/A
  • P/E Ratio
  • BOLD N/A
  • POCI N/A
  • Revenue Growth
  • BOLD N/A
  • POCI N/A
  • 52 Week Low
  • BOLD $1.06
  • POCI $3.47
  • 52 Week High
  • BOLD $12.26
  • POCI $6.90
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • POCI 61.12
  • Support Level
  • BOLD N/A
  • POCI $4.35
  • Resistance Level
  • BOLD N/A
  • POCI $4.62
  • Average True Range (ATR)
  • BOLD 0.00
  • POCI 0.28
  • MACD
  • BOLD 0.00
  • POCI 0.07
  • Stochastic Oscillator
  • BOLD 0.00
  • POCI 86.61

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

Share on Social Networks: